↓ Skip to main content

Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study

Overview of attention for article published in Frontiers in Pharmacology, September 2020
Altmetric Badge

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study
Published in
Frontiers in Pharmacology, September 2020
DOI 10.3389/fphar.2020.01308
Pubmed ID
Authors

Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K. Fielding, Daniel M. Jennings, Marina Karakantza, Saad Al-Ismail, Graham P. Collins, Stewart McConnell, Catherine Langton, Magda J. Al-Obaidi, Metod Oblak, Sam Salek

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 19%
Student > Master 2 8%
Student > Bachelor 1 4%
Professor 1 4%
Other 1 4%
Other 0 0%
Unknown 16 62%
Readers by discipline Count As %
Medicine and Dentistry 6 23%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Nursing and Health Professions 1 4%
Social Sciences 1 4%
Agricultural and Biological Sciences 1 4%
Other 0 0%
Unknown 15 58%